Skip to main content
. 2024 Oct 14;14:23971. doi: 10.1038/s41598-024-74804-8

Table 3.

Comparison of sleep quality and its subscales between study groups.

Variable (Score range) Dark chocolate (n = 30) Milk chocolate (n = 30) P-value ES
Global score (0–21)
Baseline 8.4 ± 4.2 8.0 (4.8 to 11.0) 8.4 ± 4.2 8.0 (5.0 to 12.0) 0.988a -
After 8 weeks 7.3 ± 4.2 5.5 (4.8 to 10.0) 7.6 ± 4.1 6.5 (5.0 to 10.3) 0.546b -0.07
Subjective sleep quality (0–3)
Baseline 1.3 ± 1.1 1.0 (0.8 to 2.0) 1.2 ± 1.0 1.0 (0.0 to 2.0) 0.815 b -
After 8 weeks 1.1 ± 1.1 1.0 (0.0 to 2.0) 1.2 ± 1.1 1.0 (0.0 to 2.0) 0.780 b -0.09
Sleep latency (0–3)
Baseline 1.2 ± 0.8 1.0 (0.8 to 2.0) 1.3 ± 1.0 1.0 (0.8 to 2.0) 0.596 b -
After 8 weeks 1.1 ± 1.1 1.0 (0.0 to 1.3) 1.3 ± 1.0 1.0 (0.8 to 2.0) 0.145 b -0.19
Sleep duration (0–3)
Baseline 1.8 ± 0.8 2.0 (1.0 to 2.0) 1.7 ± 1.0 2.0 (1.0 to 2.3) 0.863 b -
After 8 weeks 1.6 ± 0.9 2.0 (1.0 to 2.0) 1.3 ± 0.8 1.5 (1.0 to 2.0) 0.260 b 0.35
Sleep efficacy (0–3)
Baseline 0.8 ± 1.2 0.0 (0.0 to 2.0) 0.7 ± 1.1 0.0 (0.0 to 1.3) 0.850 b -
After 8 weeks 0.6 ± 0.9 0.0 (0.0 to 1.0) 0.6 ± 1.1 0.0 (0.0 to 1.0) 0.715 b 0.00
Sleep disturbances (0–3)
Baseline 1.6 ± 0.6 2.0 (1.0 to 2.0) 1.5 ± 0.6 1.5 (1.0 to 2.0) 0.720 b -
After 8 weeks 1.4 ± 0.6 1.0 (1.0 to 2.0) 1.3 ± 0.6 1.0 (1.0 to 2.0) 0.684 b 0.17
Use of sleep medication (0–3)
Baseline 0.2 ± 0.8 0.0 (0.0 to 0.0) 0.2 ± 0.7 0.0 (0.0 to 0.0) 0.688 b -
After 8 weeks 0.1 ± 0.6 0.0 (0.0 to 0.0) 0.2 ± 0.5 0.0 (0.0 to 0.0) 0.655 b -0.18
Daytime dysfunction (0–3)
Baseline 1.6 ± 0.8 2.0 (1.0 to 2.0) 1.7 ± 0.9 2.0 (1.0 to 2.3) 0.614 b -
After 8 weeks 1.4 ± 0.8 1.0 (1.0 to 2.0) 1.7 ± 0.9 2.0 (1.0 to 2.0) 0.134 b -0.35

Data were presented as mean ± standard deviation or median (percentile 25 to percentile 75), a Independent t-test, b Mann–Whitney U test, ES: effect size (Cohen’s d).